Skip to content
Subscribe
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Quest Blog
Podcast
Newsletter
Sujatha Gurunathan
Blog Post
Clinical Trial Alert: Phase 2 Study of Oral Ifetroban in Individuals with DMD
By
Sujatha Gurunathan
|
August 10, 2022
Blog Post
Simply Stated: What is Myasthenia Gravis (MG)?
By
Sujatha Gurunathan
|
June 27, 2022
Blog Post
Eledon Announces Positive Topline Results from a Phase 2a Study of Tegoprubart to Treat ALS
By
Sujatha Gurunathan
|
June 1, 2022
Blog Post
Simply Stated: What is Friedreich’s Ataxia (FRDA)?
By
Sujatha Gurunathan
|
May 31, 2022
Blog Post
Research Study Alert: Track-ALS Study of Home-Based Digital Monitoring to Assess ALS Progression
By
Sujatha Gurunathan
|
May 23, 2022
Blog Post
Clinical Trial Alert: Phase 3 Study of investigational drug in Adults Living with ALS
By
Sujatha Gurunathan
|
May 17, 2022
Blog Post
FDA Approves MTPA’s RADICAVA ORS for Treatment of ALS
By
Sujatha Gurunathan
|
May 13, 2022
Blog Post
Research Study Alert: Study of Wearable Gait Sensor in People with or without Neuromuscular Disease
By
Sujatha Gurunathan
|
May 2, 2022
FDA Approves Alexion’s Ultomiris for Treatment of gMG
By
Sujatha Gurunathan
|
April 28, 2022
Blog Post
Simply Stated: Inclusion Body Myositis, Revisited
By
Sujatha Gurunathan
|
April 27, 2022
1
2
3
…
5
Next »
Skip to content
Open toolbar
Accessibility Tools
Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset